Type 1 Diabetes: Hybrid Closed-Loop and Open-Loop ... Dec. 18, 2024 — Until now, scientists have been unable to determine how metformin, a Type 2 diabetes medication that lowers blood sugar ...
Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.
A recent study has found that a class of diabetes drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors may increase ...
Daily metformin with or without ... a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported in JAMA Network Open.
Consultant in endocrinology and diabetes Professor Vinod Patel discusses current recommended pharmacological treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results